A - MEDICA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
A - MEDICA
Largest movements
- Receivables within one year +€5,355
up €5,355 (+15.5%), from €34,645 to €40,000
of which Trade receivables: +€5,500
- Short-term financial debts +€2,892
new in 2025: €2,892
- Other debts +€2,569
up €2,569 (+5.9%), from €43,864 to €46,433
- Trade debts -€1,537
down €1,537 (-20.5%), from €7,507 to €5,970
- Financial charges -€1,072
down €1,072 (-57.2%), from €1,874 to €802
- Gross operating margin -€1,026
down €1,026 (-40.8%), from €2,514 to €1,488
- Taxes +€461
up €461 (+461%), from €100 to €561
- Depreciation -€376
no longer reported in 2025 (was €376)
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €100,651 | €105,140 | +€4,489 | +4.5% |
| Fixed assets | 21/28 | €65,140 | €65,140 | = | 0.0% |
| Financial fixed assets | 28 | €65,140 | €65,140 | = | 0.0% |
| Current assets | 29/58 | €35,511 | €40,000 | +€4,489 | +12.6% |
| Amounts receivable within one year | 40/41 | €34,645 | €40,000 | +€5,355 | +15.5% |
| Trade receivables | 40 | €34,500 | €40,000 | +€5,500 | +15.9% |
| Other amounts receivable | 41 | €145 | - | -€145 | |
| Cash at bank and in hand | 54/58 | €866 | - | -€866 | |
| Total equity and liabilities | 10/49 | €100,651 | €105,140 | +€4,489 | +4.5% |
| Equity | 10/15 | €49,180 | €49,305 | +€125 | +0.3% |
| Contributions | 10/11 | €64,400 | €64,400 | = | 0.0% |
| Reserves | 13 | €235 | €235 | = | 0.0% |
| Non-distributable reserves | 130/1 | €235 | €235 | = | 0.0% |
| Reserves not available under the articles | 1311 | €235 | €235 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€15,455 | -€15,330 | +€125 | +0.8% |
| Amounts payable | 17/49 | €51,471 | €55,835 | +€4,364 | +8.5% |
| Amounts payable within one year | 42/48 | €51,471 | €55,835 | +€4,364 | +8.5% |
| Financial debts | 43 | - | €2,892 | +€2,892 | |
| Credit institutions | 430/8 | - | €2,892 | +€2,892 | |
| Trade debts | 44 | €7,507 | €5,970 | -€1,537 | -20.5% |
| Suppliers | 440/4 | €7,507 | €5,970 | -€1,537 | -20.5% |
| Taxes, remuneration and social security | 45 | €100 | €540 | +€440 | +440% |
| Taxes | 450/3 | €100 | €540 | +€440 | +440% |
| Other amounts payable | 47/48 | €43,864 | €46,433 | +€2,569 | +5.9% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €376 | - | -€376 | |
| Gross operating margin | 9900 | €2,514 | €1,488 | -€1,026 | -40.8% |
| Operating profit (loss) | 9901 | €2,138 | €1,488 | -€650 | -30.4% |
| Financial charges | 65/66B | €1,874 | €802 | -€1,072 | -57.2% |
| Recurring financial charges | 65 | €1,874 | €802 | -€1,072 | -57.2% |
| Profit (loss) for the period before taxes | 9903 | €264 | €686 | +€422 | +160% |
| Income taxes | 67/77 | €100 | €561 | +€461 | +461% |
| Profit (loss) for the period | 9904 | €164 | €125 | -€39 | -23.8% |
| Profit (loss) for the period to be appropriated | 9905 | €164 | €125 | -€39 | -23.8% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 19 October 2026 via checked.be.